In Reply

This letter to the editor remarks on additional considerations for the management of febrile neutropenia during the COVID‐19 pandemic, in response to the letter by Boutayeb et al.

Detalles Bibliográficos
Autores principales: Coomes, Eric A., Al‐Shamsi, Humaid O., Meyers, Brandon M., Alhazzani, Waleed, Alhuraiji, Ahmad, Chemaly, Roy F., Almuhanna, Meshari, Wolff, Robert A., Ibrahim, Nuhad K., Chua, Melvin L.K., Hotte, Sebastien J., Elfiki, Tarek, Curigliano, Giuseppe, Eng, Cathy, Grothey, Axel, Xie, Conghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267302/
https://www.ncbi.nlm.nih.gov/pubmed/32378772
http://dx.doi.org/10.1634/theoncologist.2020-0329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267302/
https://www.ncbi.nlm.nih.gov/pubmed/32378772
http://dx.doi.org/10.1634/theoncologist.2020-0329

Ejemplares similares